Read + Share
Amedeo Smart
Independent Medical Education
Donker HC, Cuppens K, Froyen G, Groen HJM, et al. Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer. Lung Cancer 2023;182:107286.PMID: 37421934
Email
LinkedIn
Facebook
Twitter
Privacy Policy